As you all are aware of this year, we have published a lot of brilliant reviews on some of the hottest topics in the Biotech Industry! This article highlights our favourite ones for 2015! Click the titles to read more…
CRISPR has an enormous potential in therapeutic development and many Biotech and Big Pharma companies are already researching into the area. This review explains what CRISPR actually is, the mechanisms behind it and how it could be utilized for therapeutics.
The microbial cells inhabiting our body make up what is called the “microbiome” and this field is very new in Biotech. Recently, evidence has been presented that suggests immunotherapy is reliant on this gut microflora. This review goes into depth on what microbiome companies are doing in the immuno-oncology area.
The Biotech Industry has and will continue to play a major role in the treatment of cancers. This review goes into greater detail of these treatments, including monoclonal antibodies, gene therapy and CAR-T. It goes on to explain what is next between Biotech and oncology.
Alzheimer’s and Parkinson’s affects 50 million people worldwide and the biotech industry is a major player in researching treatment for these diseases. This review gives a brief summary on a selection of neurodegenerative diseases and the research that is being put into them.
Rare diseases are a major focus of many Biotech companies for a number of reasons. This review looks deeper into some of these companies to find out why they are looking into these rare diseases and understand the changes happening.
CAR-T has been arguably the hottest topic of 2015 within the oncology field of Biotech. This review explains what this specific Cell Therapy actually is, how it can be turned into a product and the front runners of CAR-T race. We definitely have not seen the end of this game-changing cell.